Concepts (343)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Air Pollutants | 24 | 2025 | 115 | 5.980 |
Why?
|
| Air Pollution | 18 | 2024 | 75 | 4.430 |
Why?
|
| Environmental Exposure | 22 | 2024 | 236 | 3.760 |
Why?
|
| Particulate Matter | 19 | 2025 | 80 | 3.750 |
Why?
|
| Maternal Exposure | 22 | 2025 | 155 | 3.730 |
Why?
|
| Occupational Exposure | 27 | 2022 | 131 | 3.410 |
Why?
|
| Environmental Monitoring | 25 | 2022 | 91 | 3.200 |
Why?
|
| Metals, Heavy | 3 | 2021 | 23 | 1.900 |
Why?
|
| Texas | 37 | 2025 | 3664 | 1.880 |
Why?
|
| Stillbirth | 3 | 2019 | 103 | 1.740 |
Why?
|
| Cyclonic Storms | 4 | 2021 | 80 | 1.640 |
Why?
|
| Industry | 10 | 2021 | 29 | 1.620 |
Why?
|
| Metals | 4 | 2023 | 66 | 1.610 |
Why?
|
| Community-Based Participatory Research | 2 | 2023 | 56 | 1.450 |
Why?
|
| Arsenic | 4 | 2023 | 48 | 1.450 |
Why?
|
| Residence Characteristics | 6 | 2020 | 290 | 1.430 |
Why?
|
| Disasters | 3 | 2021 | 106 | 1.390 |
Why?
|
| Mexican Americans | 6 | 2018 | 169 | 1.310 |
Why?
|
| Environmental Pollutants | 6 | 2018 | 80 | 1.270 |
Why?
|
| Premature Birth | 5 | 2018 | 418 | 1.270 |
Why?
|
| Prenatal Exposure Delayed Effects | 6 | 2024 | 243 | 1.260 |
Why?
|
| Ozone | 3 | 2019 | 20 | 1.200 |
Why?
|
| Oil and Gas Industry | 2 | 2018 | 5 | 1.130 |
Why?
|
| Stress, Psychological | 6 | 2021 | 604 | 1.110 |
Why?
|
| Pregnancy | 32 | 2025 | 7592 | 1.090 |
Why?
|
| Environmental Health | 3 | 2023 | 16 | 1.010 |
Why?
|
| Nitrogen Dioxide | 7 | 2024 | 18 | 0.890 |
Why?
|
| Recycling | 2 | 2020 | 5 | 0.840 |
Why?
|
| Soil Pollutants | 1 | 2021 | 13 | 0.740 |
Why?
|
| Polycyclic Aromatic Hydrocarbons | 7 | 2022 | 77 | 0.730 |
Why?
|
| Volatile Organic Compounds | 2 | 2020 | 13 | 0.730 |
Why?
|
| Deer | 1 | 2021 | 15 | 0.700 |
Why?
|
| Adult | 46 | 2025 | 31617 | 0.690 |
Why?
|
| Vulnerable Populations | 2 | 2020 | 148 | 0.690 |
Why?
|
| Population Dynamics | 2 | 2019 | 34 | 0.690 |
Why?
|
| Disaster Planning | 1 | 2021 | 64 | 0.680 |
Why?
|
| Pregnancy Outcome | 3 | 2019 | 637 | 0.670 |
Why?
|
| Public-Private Sector Partnerships | 1 | 2020 | 18 | 0.660 |
Why?
|
| Fires | 1 | 2020 | 12 | 0.650 |
Why?
|
| Benzene | 7 | 2020 | 24 | 0.640 |
Why?
|
| Abruptio Placentae | 1 | 2019 | 16 | 0.630 |
Why?
|
| Humans | 98 | 2025 | 133192 | 0.620 |
Why?
|
| Temperature | 1 | 2019 | 325 | 0.590 |
Why?
|
| Diabetes, Gestational | 1 | 2020 | 115 | 0.590 |
Why?
|
| Natural Gas | 1 | 2018 | 5 | 0.580 |
Why?
|
| Young Adult | 23 | 2023 | 9921 | 0.570 |
Why?
|
| Female | 66 | 2025 | 71395 | 0.570 |
Why?
|
| Logistic Models | 14 | 2019 | 1862 | 0.550 |
Why?
|
| Trace Elements | 1 | 2017 | 26 | 0.520 |
Why?
|
| Urban Population | 6 | 2019 | 242 | 0.510 |
Why?
|
| Butadienes | 1 | 2016 | 21 | 0.510 |
Why?
|
| Hazardous Substances | 5 | 2015 | 18 | 0.500 |
Why?
|
| Social Class | 2 | 2017 | 207 | 0.490 |
Why?
|
| Models, Statistical | 7 | 2024 | 499 | 0.480 |
Why?
|
| Leukemia | 1 | 2019 | 374 | 0.480 |
Why?
|
| Community Participation | 1 | 2015 | 42 | 0.470 |
Why?
|
| Multilingualism | 1 | 2015 | 43 | 0.470 |
Why?
|
| Colorectal Neoplasms | 4 | 2014 | 638 | 0.470 |
Why?
|
| Inhalation Exposure | 5 | 2020 | 36 | 0.460 |
Why?
|
| Surveys and Questionnaires | 9 | 2021 | 3985 | 0.450 |
Why?
|
| Air Pollutants, Occupational | 7 | 2006 | 17 | 0.450 |
Why?
|
| Hypertension | 3 | 2018 | 1402 | 0.430 |
Why?
|
| Occupational Diseases | 6 | 2016 | 74 | 0.430 |
Why?
|
| Case-Control Studies | 12 | 2019 | 3408 | 0.430 |
Why?
|
| Models, Theoretical | 7 | 2015 | 395 | 0.430 |
Why?
|
| Birth Weight | 6 | 2025 | 355 | 0.430 |
Why?
|
| Pilot Projects | 5 | 2020 | 1467 | 0.410 |
Why?
|
| Birth Certificates | 3 | 2019 | 13 | 0.390 |
Why?
|
| Risk Assessment | 7 | 2021 | 3715 | 0.380 |
Why?
|
| Cohort Studies | 12 | 2022 | 5191 | 0.370 |
Why?
|
| Infant, Newborn | 16 | 2025 | 8628 | 0.370 |
Why?
|
| Endocrine Disruptors | 2 | 2022 | 54 | 0.360 |
Why?
|
| Legionellosis | 1 | 2011 | 4 | 0.360 |
Why?
|
| Water Supply | 2 | 2004 | 27 | 0.350 |
Why?
|
| Linear Models | 7 | 2017 | 719 | 0.350 |
Why?
|
| Mercury | 2 | 2001 | 30 | 0.350 |
Why?
|
| Socioeconomic Factors | 6 | 2020 | 908 | 0.350 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2016 | 818 | 0.350 |
Why?
|
| Water Pollutants, Chemical | 2 | 2004 | 40 | 0.340 |
Why?
|
| Nickel | 2 | 2001 | 24 | 0.340 |
Why?
|
| Bayes Theorem | 7 | 2024 | 310 | 0.340 |
Why?
|
| Asthma | 7 | 2014 | 807 | 0.340 |
Why?
|
| Cities | 2 | 2020 | 51 | 0.330 |
Why?
|
| Polybrominated Biphenyls | 2 | 2007 | 6 | 0.320 |
Why?
|
| Particle Size | 4 | 2022 | 148 | 0.320 |
Why?
|
| Odds Ratio | 10 | 2016 | 1253 | 0.310 |
Why?
|
| Gestational Age | 5 | 2022 | 1230 | 0.310 |
Why?
|
| Disease Outbreaks | 1 | 2011 | 329 | 0.300 |
Why?
|
| Respiratory Tract Diseases | 3 | 2020 | 81 | 0.300 |
Why?
|
| Disinfection | 2 | 2011 | 29 | 0.300 |
Why?
|
| Agriculture | 2 | 2006 | 33 | 0.300 |
Why?
|
| Cognition Disorders | 1 | 2013 | 578 | 0.300 |
Why?
|
| Pesticides | 3 | 2022 | 30 | 0.300 |
Why?
|
| Risk Factors | 17 | 2019 | 10936 | 0.290 |
Why?
|
| Male | 38 | 2023 | 65480 | 0.270 |
Why?
|
| Mining | 4 | 2010 | 7 | 0.270 |
Why?
|
| Metallurgy | 4 | 2000 | 6 | 0.270 |
Why?
|
| United States | 24 | 2019 | 11711 | 0.260 |
Why?
|
| Pregnancy Trimesters | 2 | 2018 | 34 | 0.260 |
Why?
|
| Aerosols | 3 | 2022 | 65 | 0.250 |
Why?
|
| Carcinogens, Environmental | 2 | 2015 | 13 | 0.250 |
Why?
|
| Infant, Small for Gestational Age | 2 | 2016 | 61 | 0.250 |
Why?
|
| Prevalence | 11 | 2018 | 2628 | 0.240 |
Why?
|
| Biomarkers | 6 | 2017 | 3411 | 0.240 |
Why?
|
| Styrene | 4 | 2001 | 4 | 0.230 |
Why?
|
| Chemical Industry | 4 | 2001 | 7 | 0.230 |
Why?
|
| Cleft Lip | 2 | 2017 | 133 | 0.220 |
Why?
|
| Cleft Palate | 2 | 2017 | 153 | 0.220 |
Why?
|
| Risk | 3 | 2019 | 781 | 0.220 |
Why?
|
| Trihalomethanes | 1 | 2004 | 5 | 0.220 |
Why?
|
| SEER Program | 3 | 2014 | 222 | 0.220 |
Why?
|
| Antineoplastic Agents | 2 | 2014 | 1849 | 0.210 |
Why?
|
| United States Environmental Protection Agency | 3 | 2019 | 8 | 0.200 |
Why?
|
| Databases, Factual | 3 | 2004 | 1240 | 0.200 |
Why?
|
| Data Collection | 4 | 2023 | 395 | 0.200 |
Why?
|
| Cobalt | 1 | 2022 | 18 | 0.190 |
Why?
|
| Tungsten | 1 | 2022 | 6 | 0.190 |
Why?
|
| Health Surveys | 3 | 2020 | 259 | 0.190 |
Why?
|
| Middle Aged | 20 | 2021 | 28912 | 0.180 |
Why?
|
| Glyoxylates | 1 | 2001 | 4 | 0.180 |
Why?
|
| Mandelic Acids | 1 | 2001 | 6 | 0.180 |
Why?
|
| Child | 10 | 2024 | 25849 | 0.180 |
Why?
|
| Toluene | 3 | 2010 | 11 | 0.180 |
Why?
|
| Seroepidemiologic Studies | 1 | 2021 | 142 | 0.180 |
Why?
|
| Xylenes | 3 | 2010 | 13 | 0.180 |
Why?
|
| Benzene Derivatives | 3 | 2010 | 19 | 0.180 |
Why?
|
| Soil | 1 | 2021 | 72 | 0.180 |
Why?
|
| China | 1 | 2021 | 292 | 0.170 |
Why?
|
| Floods | 1 | 2021 | 18 | 0.170 |
Why?
|
| Respiratory Protective Devices | 1 | 2020 | 8 | 0.170 |
Why?
|
| Attention Deficit Disorder with Hyperactivity | 1 | 2023 | 238 | 0.170 |
Why?
|
| Exercise | 2 | 2017 | 873 | 0.170 |
Why?
|
| Women, Working | 2 | 2017 | 9 | 0.170 |
Why?
|
| Spinal Dysraphism | 3 | 2015 | 274 | 0.170 |
Why?
|
| Cadmium | 1 | 2020 | 31 | 0.160 |
Why?
|
| Reproducibility of Results | 5 | 2007 | 3043 | 0.160 |
Why?
|
| Food Contamination | 3 | 2007 | 29 | 0.160 |
Why?
|
| Soot | 1 | 2020 | 14 | 0.160 |
Why?
|
| Vehicle Emissions | 2 | 2022 | 20 | 0.160 |
Why?
|
| Feasibility Studies | 4 | 2017 | 823 | 0.160 |
Why?
|
| Styrenes | 3 | 1996 | 6 | 0.160 |
Why?
|
| Weather | 1 | 2019 | 14 | 0.160 |
Why?
|
| Aged | 14 | 2021 | 21448 | 0.160 |
Why?
|
| Universities | 1 | 2020 | 129 | 0.160 |
Why?
|
| Regression Analysis | 5 | 2014 | 808 | 0.160 |
Why?
|
| Urban Health | 1 | 2019 | 78 | 0.160 |
Why?
|
| RNA, Viral | 1 | 2021 | 562 | 0.150 |
Why?
|
| Oil and Gas Fields | 1 | 2019 | 9 | 0.150 |
Why?
|
| Sister Chromatid Exchange | 2 | 1996 | 14 | 0.150 |
Why?
|
| Child, Preschool | 8 | 2024 | 14865 | 0.150 |
Why?
|
| Adolescent | 13 | 2021 | 20550 | 0.150 |
Why?
|
| Registries | 3 | 2019 | 1582 | 0.150 |
Why?
|
| Hypersensitivity | 1 | 2021 | 195 | 0.150 |
Why?
|
| Analysis of Variance | 5 | 2001 | 1033 | 0.140 |
Why?
|
| Drinking Behavior | 1 | 1998 | 9 | 0.140 |
Why?
|
| Cross-Over Studies | 1 | 2019 | 332 | 0.140 |
Why?
|
| Contraceptives, Oral | 1 | 2017 | 41 | 0.140 |
Why?
|
| Geography, Medical | 1 | 2017 | 16 | 0.140 |
Why?
|
| Sensitivity and Specificity | 2 | 2021 | 2139 | 0.140 |
Why?
|
| Occupations | 1 | 2017 | 20 | 0.140 |
Why?
|
| Fluorocarbons | 1 | 2017 | 60 | 0.130 |
Why?
|
| Workplace | 2 | 2015 | 82 | 0.130 |
Why?
|
| Prostatic Neoplasms | 1 | 2006 | 1602 | 0.130 |
Why?
|
| Retrospective Studies | 7 | 2025 | 17526 | 0.130 |
Why?
|
| Epoxy Compounds | 1 | 1996 | 20 | 0.130 |
Why?
|
| Fetal Development | 3 | 2022 | 135 | 0.130 |
Why?
|
| Molecular Weight | 1 | 2017 | 384 | 0.130 |
Why?
|
| Neural Tube Defects | 2 | 2010 | 359 | 0.130 |
Why?
|
| DNA Adducts | 1 | 1996 | 71 | 0.130 |
Why?
|
| Serum Albumin | 1 | 1996 | 115 | 0.130 |
Why?
|
| Phthalic Acids | 1 | 2016 | 10 | 0.130 |
Why?
|
| Reproductive History | 1 | 1995 | 10 | 0.120 |
Why?
|
| Lead | 1 | 1995 | 24 | 0.120 |
Why?
|
| International Agencies | 1 | 2015 | 30 | 0.120 |
Why?
|
| Antibodies, Viral | 1 | 2021 | 1205 | 0.120 |
Why?
|
| Publications | 1 | 2015 | 35 | 0.110 |
Why?
|
| Vitamin D Deficiency | 1 | 2016 | 76 | 0.110 |
Why?
|
| Cause of Death | 2 | 2014 | 504 | 0.110 |
Why?
|
| Menopause | 1 | 1995 | 90 | 0.110 |
Why?
|
| Chlamydia trachomatis | 1 | 2014 | 27 | 0.110 |
Why?
|
| Papillomaviridae | 1 | 2016 | 187 | 0.110 |
Why?
|
| Focus Groups | 1 | 2015 | 215 | 0.110 |
Why?
|
| Cross-Sectional Studies | 7 | 2016 | 3735 | 0.110 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2023 | 998 | 0.110 |
Why?
|
| Aged, 80 and over | 7 | 2014 | 7137 | 0.110 |
Why?
|
| Chlamydia Infections | 1 | 2014 | 49 | 0.110 |
Why?
|
| Azithromycin | 1 | 2014 | 46 | 0.110 |
Why?
|
| Motor Activity | 2 | 2015 | 528 | 0.110 |
Why?
|
| Juvenile Delinquency | 1 | 2014 | 25 | 0.110 |
Why?
|
| Prisoners | 1 | 2014 | 38 | 0.110 |
Why?
|
| Occupational Health | 3 | 2010 | 48 | 0.110 |
Why?
|
| Environment Design | 1 | 2014 | 17 | 0.110 |
Why?
|
| Vitamin D | 1 | 2016 | 180 | 0.110 |
Why?
|
| Nutrition Surveys | 5 | 2016 | 314 | 0.110 |
Why?
|
| North America | 3 | 2000 | 265 | 0.110 |
Why?
|
| Iron | 1 | 2017 | 304 | 0.110 |
Why?
|
| Smoking | 3 | 1996 | 943 | 0.110 |
Why?
|
| Doxycycline | 1 | 2014 | 121 | 0.110 |
Why?
|
| Europe | 3 | 2000 | 373 | 0.100 |
Why?
|
| Uncertainty | 1 | 2014 | 104 | 0.100 |
Why?
|
| Erectile Dysfunction | 1 | 2016 | 213 | 0.100 |
Why?
|
| Population Surveillance | 3 | 2012 | 415 | 0.100 |
Why?
|
| Craniosynostoses | 1 | 2015 | 134 | 0.100 |
Why?
|
| Liver Neoplasms | 1 | 2023 | 1405 | 0.100 |
Why?
|
| Insurance Claim Reporting | 1 | 2012 | 8 | 0.100 |
Why?
|
| Poverty | 2 | 2015 | 437 | 0.100 |
Why?
|
| Alcohol Drinking | 1 | 1995 | 361 | 0.100 |
Why?
|
| Infant | 7 | 2024 | 13237 | 0.100 |
Why?
|
| Diphosphonates | 1 | 2012 | 43 | 0.100 |
Why?
|
| Polychlorinated Biphenyls | 2 | 2003 | 12 | 0.100 |
Why?
|
| Iron, Dietary | 1 | 2012 | 17 | 0.090 |
Why?
|
| Cardiovascular Diseases | 3 | 2014 | 2092 | 0.090 |
Why?
|
| Maintenance | 1 | 2011 | 1 | 0.090 |
Why?
|
| Epidemiologic Studies | 2 | 2002 | 41 | 0.090 |
Why?
|
| Gastroschisis | 1 | 2012 | 56 | 0.090 |
Why?
|
| Health Personnel | 2 | 2006 | 549 | 0.090 |
Why?
|
| Papillomavirus Infections | 1 | 2016 | 397 | 0.090 |
Why?
|
| Zinc | 1 | 2012 | 141 | 0.090 |
Why?
|
| Equipment Contamination | 1 | 2011 | 41 | 0.090 |
Why?
|
| Demography | 3 | 2007 | 243 | 0.090 |
Why?
|
| Animals | 4 | 2021 | 36191 | 0.090 |
Why?
|
| Anencephaly | 1 | 2010 | 11 | 0.080 |
Why?
|
| Pregnancy Complications | 1 | 2015 | 553 | 0.080 |
Why?
|
| Age Factors | 4 | 2015 | 2954 | 0.080 |
Why?
|
| Time Factors | 5 | 2001 | 6541 | 0.080 |
Why?
|
| Gasoline | 2 | 2022 | 4 | 0.080 |
Why?
|
| Parity | 2 | 2007 | 87 | 0.080 |
Why?
|
| Creatinine | 2 | 2001 | 416 | 0.080 |
Why?
|
| Infant, Premature | 1 | 2014 | 858 | 0.080 |
Why?
|
| Follow-Up Studies | 2 | 2020 | 5435 | 0.070 |
Why?
|
| Manufactured Materials | 2 | 1998 | 2 | 0.070 |
Why?
|
| Research Design | 2 | 2007 | 757 | 0.070 |
Why?
|
| Prospective Studies | 5 | 2022 | 6571 | 0.070 |
Why?
|
| Longitudinal Studies | 3 | 2003 | 1514 | 0.070 |
Why?
|
| Metabolic Syndrome | 1 | 2012 | 365 | 0.070 |
Why?
|
| Incidence | 4 | 2023 | 3385 | 0.070 |
Why?
|
| Japan | 2 | 1998 | 152 | 0.070 |
Why?
|
| Bone Neoplasms | 1 | 2012 | 446 | 0.070 |
Why?
|
| Dementia | 1 | 2013 | 489 | 0.070 |
Why?
|
| Cognition | 2 | 2024 | 816 | 0.070 |
Why?
|
| Computer Simulation | 2 | 2024 | 708 | 0.070 |
Why?
|
| Michigan | 1 | 2007 | 52 | 0.070 |
Why?
|
| Neoplasms | 2 | 2020 | 2984 | 0.070 |
Why?
|
| South Carolina | 1 | 2006 | 10 | 0.060 |
Why?
|
| Ultrasonography, Prenatal | 2 | 2022 | 1008 | 0.060 |
Why?
|
| Diet | 2 | 2011 | 1167 | 0.060 |
Why?
|
| Chlorine | 1 | 2004 | 17 | 0.050 |
Why?
|
| Statistics, Nonparametric | 2 | 2011 | 446 | 0.050 |
Why?
|
| Disinfectants | 1 | 2004 | 28 | 0.050 |
Why?
|
| Water Purification | 1 | 2004 | 18 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1556 | 0.050 |
Why?
|
| Fishes | 1 | 2003 | 38 | 0.050 |
Why?
|
| Atherosclerosis | 1 | 2011 | 1002 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2014 | 2575 | 0.050 |
Why?
|
| Confidence Intervals | 2 | 2010 | 279 | 0.050 |
Why?
|
| Alloys | 1 | 2022 | 15 | 0.050 |
Why?
|
| Health Status Disparities | 1 | 2025 | 252 | 0.050 |
Why?
|
| Antimony | 1 | 2022 | 14 | 0.050 |
Why?
|
| Fetal Weight | 1 | 2022 | 72 | 0.050 |
Why?
|
| Lung Neoplasms | 1 | 2012 | 1558 | 0.050 |
Why?
|
| Solvents | 1 | 2022 | 46 | 0.050 |
Why?
|
| Data Interpretation, Statistical | 2 | 2015 | 236 | 0.050 |
Why?
|
| Seasons | 1 | 2004 | 327 | 0.050 |
Why?
|
| Maximum Allowable Concentration | 1 | 2001 | 6 | 0.050 |
Why?
|
| Sex Characteristics | 1 | 2023 | 334 | 0.050 |
Why?
|
| Transients and Migrants | 1 | 2001 | 26 | 0.050 |
Why?
|
| Time and Motion Studies | 1 | 2001 | 23 | 0.050 |
Why?
|
| Sampling Studies | 1 | 2001 | 78 | 0.050 |
Why?
|
| Italy | 1 | 2001 | 125 | 0.040 |
Why?
|
| Sociological Factors | 1 | 2021 | 9 | 0.040 |
Why?
|
| Laboratories | 1 | 2022 | 89 | 0.040 |
Why?
|
| Medicaid | 2 | 2014 | 252 | 0.040 |
Why?
|
| Heart Defects, Congenital | 1 | 2012 | 1887 | 0.040 |
Why?
|
| Western Australia | 1 | 2000 | 5 | 0.040 |
Why?
|
| Community-Institutional Relations | 1 | 2020 | 36 | 0.040 |
Why?
|
| Receptors, Antigen, T-Cell | 1 | 2023 | 504 | 0.040 |
Why?
|
| Cluster Analysis | 1 | 2001 | 436 | 0.040 |
Why?
|
| Body Mass Index | 3 | 2010 | 1710 | 0.040 |
Why?
|
| Sex Factors | 2 | 2015 | 1350 | 0.040 |
Why?
|
| Databases, Bibliographic | 1 | 1998 | 20 | 0.040 |
Why?
|
| Baths | 1 | 1998 | 17 | 0.040 |
Why?
|
| Norway | 1 | 2017 | 29 | 0.040 |
Why?
|
| Menstruation | 1 | 2017 | 31 | 0.030 |
Why?
|
| Carcinogenicity Tests | 1 | 1996 | 21 | 0.030 |
Why?
|
| Biotransformation | 1 | 1996 | 56 | 0.030 |
Why?
|
| Dogs | 1 | 1998 | 672 | 0.030 |
Why?
|
| Employment | 1 | 2017 | 70 | 0.030 |
Why?
|
| Microsomes, Liver | 1 | 1996 | 100 | 0.030 |
Why?
|
| Time | 1 | 1996 | 101 | 0.030 |
Why?
|
| Factor Analysis, Statistical | 1 | 2016 | 236 | 0.030 |
Why?
|
| Bias | 1 | 1996 | 146 | 0.030 |
Why?
|
| Cervix Uteri | 1 | 2016 | 63 | 0.030 |
Why?
|
| Mexico | 1 | 2016 | 185 | 0.030 |
Why?
|
| Information Storage and Retrieval | 1 | 2015 | 66 | 0.030 |
Why?
|
| Workload | 1 | 2016 | 150 | 0.030 |
Why?
|
| Osteoporosis, Postmenopausal | 1 | 1995 | 31 | 0.030 |
Why?
|
| Posture | 1 | 2015 | 154 | 0.030 |
Why?
|
| Income | 1 | 1995 | 139 | 0.030 |
Why?
|
| Postmenopause | 1 | 1995 | 155 | 0.030 |
Why?
|
| Geographic Information Systems | 1 | 2014 | 41 | 0.030 |
Why?
|
| Food-Processing Industry | 1 | 1993 | 1 | 0.030 |
Why?
|
| Decision Making | 1 | 2018 | 701 | 0.030 |
Why?
|
| Public Health | 1 | 2015 | 283 | 0.020 |
Why?
|
| Health Behavior | 1 | 2015 | 400 | 0.020 |
Why?
|
| Diabetes Mellitus, Type 2 | 2 | 2014 | 1418 | 0.020 |
Why?
|
| Bone Density Conservation Agents | 1 | 2012 | 56 | 0.020 |
Why?
|
| Meat | 1 | 2012 | 46 | 0.020 |
Why?
|
| Vitamin E | 1 | 2012 | 66 | 0.020 |
Why?
|
| Heme | 1 | 2012 | 53 | 0.020 |
Why?
|
| Health Status | 1 | 2014 | 414 | 0.020 |
Why?
|
| Micronutrients | 1 | 2012 | 74 | 0.020 |
Why?
|
| Artificial Intelligence | 1 | 2015 | 297 | 0.020 |
Why?
|
| Patient Education as Topic | 1 | 2014 | 466 | 0.020 |
Why?
|
| Job Description | 1 | 2010 | 9 | 0.020 |
Why?
|
| Models, Chemical | 1 | 2011 | 90 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2014 | 1583 | 0.020 |
Why?
|
| Epidemiological Monitoring | 1 | 2011 | 63 | 0.020 |
Why?
|
| DNA | 1 | 1996 | 1675 | 0.020 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 413 | 0.020 |
Why?
|
| Construction Materials | 1 | 2010 | 4 | 0.020 |
Why?
|
| Multivariate Analysis | 2 | 2010 | 1463 | 0.020 |
Why?
|
| Proportional Hazards Models | 1 | 2014 | 1468 | 0.020 |
Why?
|
| Eating | 1 | 2012 | 393 | 0.020 |
Why?
|
| Pain | 1 | 2012 | 469 | 0.020 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2011 | 834 | 0.020 |
Why?
|
| Life Style | 2 | 2003 | 457 | 0.020 |
Why?
|
| Biomedical Research | 1 | 2015 | 551 | 0.020 |
Why?
|
| Comorbidity | 1 | 2014 | 1620 | 0.020 |
Why?
|
| Mass Screening | 1 | 2014 | 835 | 0.020 |
Why?
|
| Folic Acid | 1 | 2010 | 291 | 0.020 |
Why?
|
| Treatment Outcome | 2 | 2014 | 13094 | 0.020 |
Why?
|
| Survival Rate | 1 | 2012 | 2204 | 0.020 |
Why?
|
| Dietary Supplements | 1 | 2010 | 485 | 0.020 |
Why?
|
| Genetic Association Studies | 1 | 2010 | 860 | 0.020 |
Why?
|
| Great Lakes Region | 1 | 2003 | 1 | 0.010 |
Why?
|
| Fetal Blood | 1 | 2001 | 177 | 0.010 |
Why?
|
| Phenotype | 1 | 2010 | 4576 | 0.010 |
Why?
|
| United States Occupational Safety and Health Administration | 1 | 1997 | 3 | 0.010 |
Why?
|
| Ventilation | 1 | 1993 | 5 | 0.010 |
Why?
|
| Netherlands | 1 | 1993 | 47 | 0.010 |
Why?
|
| United Kingdom | 1 | 1993 | 241 | 0.010 |
Why?
|
| Lymphocytes | 1 | 1990 | 372 | 0.000 |
Why?
|
| Models, Biological | 1 | 1993 | 1530 | 0.000 |
Why?
|